ThursdayJan 06, 2022 12:23 pm

QualityStocksNewsBreaks – Consolidated Uranium Inc. (TSX.V: CUR) (OTCQB: CURUF) Releases Statement Regarding Promotional Activity in Response to OTC Markets Request

Consolidated Uranium (TSX.V: CUR) (OTCQB: CURUF) shared that OTC Markets Group has asked the company to provide a statement about promotional activity concerning its common shares. OTC Markets informed the company on Jan. 3, 2022, that it was aware of promotional activities concerning the company and common shares traded on the OTCQB Marketplace. That activity included the release of promotional newsletter e-mails published by the Wolf of Penny Stocks, Penny Picks and Epic Stocks Picks contained information regarding CURUF, its projects and the global uranium market as well as links to and summaries of news releases issued by the company. According…

Continue Reading

ThursdayJan 06, 2022 11:57 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Agreements Totaling $11.5M for Gross Proceeds

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system (“CNS”), has entered into securities purchase agreements with several institutional and accredited investors. The agreements outline the issue of more than 12 million shares of common stock, prefunded warrants and warrants in a private placement; the shares and warrants are offered at a purchase price of $0.95 per share. The issuance will result in an estimated $11.5 million gross proceeds for the company. Anticipated closing of the private placement is expected on or about Jan. 10,…

Continue Reading

ThursdayJan 06, 2022 11:10 am

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Strategic Advisory Board Appointment

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced the appointment of accomplished business leader and cannabis industry expert Tim Leslie as the chairman of its newly formed advisory board. Establishment of the advisory board comes as Flora continues to develop its corporate structure to include a robust roster of human capital. Leslie’s appointment aligns with the company’s goal of working with the industry’s best leaders to provide strategic counsel on matters that will fuel its growth. “We are pleased and honored to have Tim join us as the first chairman of…

Continue Reading

ThursdayJan 06, 2022 9:36 am

QualityStocksNewsBreaks – Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FRA: E4X2) Releases Update on Company Operations, Explorations

Excellon Resources (TSX: EXN) (NYSE American: EXN) (FRA: E4X2) has shared an overview of its operations. The update includes information regarding EXN’s Platosa project as well as other upcoming exploration plans; the company stated that additional updates would be forthcoming. The company noted that last year the Platosa mine and the Miguel Auza mill produced four quarters of stable production at record rates, with final numbers for 2021 expected in the next few weeks. In addition, the company has identified strategic exploration plans for each of its projects — Platosa, Evolución, Kilgore and Silver City — in 2022; Excellon is also evaluating other corporate…

Continue Reading

ThursdayJan 06, 2022 9:30 am

Cannabis Strategic Ventures Inc. (NUGS) Strengthens Foothold as Mounting Numbers Support Cannabis Legalization

An estimated 91% of U.S. adults (91%) say either that marijuana should be legal for medical and recreational use or that it should be legal for medical use only While cannabis remains an illegal substance federally, a growing number of states have legalized the substance An emerging leader in the U.S. cannabis marketplace, NUGS’ vision is to acquire, scale assets in the legal cannabis market A vast majority of adults in the United States say that marijuana should be legal for either medical and recreational use or at least for medical use, according to a recent Pew Research Center report (https://ibn.fm/zqnb9). Companies such as…

Continue Reading

ThursdayJan 06, 2022 9:30 am

InnerScope Hearing Technologies Inc. (INND) Completes Key Acquisitions as Hearing Aid Market Poised for DTC Transition in 2022

The World Health Organization estimates by 2050 nearly 2.5 billion people will have some degree of hearing loss and at least 700 million will require hearing rehabilitation InnerScope Hearing Technologies has made transformational moves in 2021 to position itself as a leader in direct-to-consumer (“DTC”) sales of hearing aids and related products InnerScope recently acquired Hearing Assist II, Walmart’s largest hearing aid provider, and iHEAR Medical, the maker of the only FDA-cleared home hearing screener, setting up for what expects to be a record Q4 2021 As our homes have become our offices, schools, restaurants, and more throughout the coronavirus…

Continue Reading

ThursdayJan 06, 2022 9:00 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Key Meeting with UK Regulatory Agency

Meeting takes company a step closer to advancing its lead investigational candidate CYB003 into clinical development CYB003 is designed for the treatment of two significant conditions: major depressive disorder (“MDD”) and alcohol use disorder (“AUD”) CEO notes that CYB003 has the potential to achieve better patient outcomes The coming year holds significant promise for Cybin (NEO: CYBN) (NYSE American: CYBN) for numerous reasons. The biopharmaceutical company has seen significant success in the execution of its strategic focus on progressing psychedelics to therapeutics, including its recent announcement that company representatives will hold a scientific advice meeting with the UK Medical and Healthcare…

Continue Reading

ThursdayJan 06, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Increases Investor Visibility with SRAX Inc. (NASDAQ: SRAX)

The strategic move to incorporate SRAX is designed to bring investor visibility for all of the upcoming events that Lexaria has planned for 2022 Lexaria’s patented DehydraTECH(TM) technology is poised to leverage multiple industries – notably the CBD industry, with a projected value of $108.8 billion by 2027 The advertising and media contract will allow SRAX to engage and manage social media companies for the creation and distribution of advertising materials promoting Lexaria Bioscience Lexaria Bioscience (NASDAQ: LEXX), an innovator of drug delivery platforms, announced that it will kick off 2022 with an advertising and media agreement with SRAX (NASDAQ:…

Continue Reading

ThursdayJan 06, 2022 9:00 am

Friendable Inc.’s (FDBL) Fan Pass Live Platform Announces January Contest on Instagram; Winter Merchandise Collection Available in Dedicated Online Shop

Besides the monthly contest prizes, artists who promote three of their streams on Instagram and tag @fanpasslive have the opportunity to earn an additional $30 this month Fan Pass Live’s Winter Merchandise Collection is now available for purchase on the website – the merchandise is Fan Pass branded and features items like hoodies, socks, beanies, sweatpants, and more Fan Pass Live Artist Pro subscriptions are available for $8.99 per month and provide extra perks for artists on the platform Mobile technology and marketing company Friendable Inc.’s (OTC: FDBL) Fan Pass Live platform has released its January contest for artists. The…

Continue Reading

WednesdayJan 05, 2022 2:29 pm

QualityStocksNewsBreaks – RYAH Group Inc.’s (CSE: RYAH) Innovative Portfolio Powers Research Insights

RYAH Group (CSE: RYAH) is the leader in volume-control technology for plant-based medicine. The company supports cannabis research for the treatment of cancer “with innovative technology that collects, analyzes and leverages objective data on therapeutic plant usage. By using the company’s smart devices and integrated AI-powered platform, patients and doctors can stay on top of prescription treatments in a safe, secure and seamless way,” reads a recent article. “RYAH’s current portfolio integrates IoT devices, medicine-carrying components and mobile applications to create an ecosystem that enables practitioners and patients to administer treatments, control volume, collect data and produce analytics that can…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered